• 1. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 2. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 3. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 4. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 5. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Cumenes

Introduction to Propofol Isopropyl Ether (CAS No. 141214-18-8)

Propofol Isopropyl Ether, chemically identified by the CAS number 141214-18-8, is a compound of significant interest in the field of pharmaceutical chemistry and anesthetic applications. This introduction delves into the compound's properties, synthesis, applications, and recent advancements in research that highlight its importance.

The molecular structure of Propofol Isopropyl Ether consists of a propofol backbone with an isopropyl ether substituent, which imparts unique physicochemical properties to the molecule. Propofol itself is well-known for its use as an intravenous anesthetic, and the introduction of the isopropyl ether moiety further enhances its pharmacological profile. This modification has been explored to improve solubility, metabolic stability, and overall efficacy in clinical settings.

In terms of synthesis, Propofol Isopropyl Ether is typically prepared through a series of organic reactions that involve the introduction of the isopropyl ether group onto the propofol molecule. These synthetic pathways often require precise control over reaction conditions to ensure high yield and purity. Advanced techniques such as catalytic hydrogenation and etherification have been employed to optimize the synthesis process.

The compound's applications extend beyond anesthetic use. Recent studies have demonstrated its potential in drug delivery systems, where its lipophilic nature makes it an excellent candidate for formulating nanoparticles and micelles. These delivery systems can enhance the bioavailability of various therapeutic agents, making Propofol Isopropyl Ether a valuable component in developing novel pharmaceutical formulations.

One of the most compelling aspects of Propofol Isopropyl Ether is its role in targeted drug delivery. Researchers have been investigating its use in creating stimuli-responsive nanoparticles that can release therapeutic agents in response to specific biological triggers. This approach has shown promise in treating diseases such as cancer, where localized drug delivery can minimize side effects and improve treatment outcomes.

Moreover, Propofol Isopropyl Ether has been studied for its potential in regenerative medicine. Its ability to promote cell proliferation and differentiation has led to experiments involving tissue engineering applications. By integrating this compound into biomaterials, scientists aim to develop scaffolds that can support tissue growth and repair, offering new hope for patients with degenerative conditions.

The compound's interaction with biological systems has also been a focal point of research. Studies have explored how Propofol Isopropyl Ether affects various cellular pathways, including those involved in inflammation and oxidative stress. Understanding these interactions can lead to the development of new therapeutic strategies for conditions like neurodegenerative diseases and cardiovascular disorders.

In conclusion, Propofol Isopropyl Ether (CAS No. 141214-18-8) represents a fascinating compound with diverse applications in pharmaceuticals and biotechnology. Its unique chemical properties make it a valuable tool for developing advanced drug delivery systems, targeted therapies, and regenerative medicine solutions. As research continues to uncover new possibilities, this compound is poised to play a significant role in future medical advancements.

• 137818-72-5(Benzene, (1-methylethoxy)(1-methylethyl)-)
• 141214-17-7(Benzene, 1-(1-methylethoxy)-2,4-bis(1-methylethyl)-)
• 14366-59-7(Isopropyl 2-Isopropylphenyl Ether)
• 75567-13-4(Benzeneethanol, b-(1,1-dimethylethoxy)-)
• 141214-19-9(Benzene, 2-(1-methylethoxy)-1,3,5-tris(1-methylethyl)-)
• 141266-07-1(Benzene, 1-(1,1-dimethylethoxy)-2-ethyl-)
• 140199-05-9(Phenol, 2-(1,1-dimethylethyl)-4-[[4-(1-methylethoxy)phenyl]methyl]-)
• 78014-31-0(Ethanol,2-[2-(1-methylethyl)phenoxy]-)
• 56949-57-6(2-(2,6-diisopropylphenoxy)ethanol)
• 128364-77-2(Benzene, 1,4-bis(1,1-dimethylethyl)-2,5-bis(1-methylethoxy)-)